Global /Australia /Healthcare /Medical Care Facilities /BDX

BCAL Diagnostics Ltd.

BDX

• ASX: BDX • Delayed

0.0830AUD 3.8%

0.0585 USD

As of 7 June 2026, BCAL Diagnostics Ltd. has a market cap of $21.05M USD, ranking #36756 globally and #1062 in Australia. It ranks #3303 in the Healthcare sector, and #400 in the Medical Care Facilities industry.

Global Rank

36756

Country Rank

1062

Sector Rank

3303

Industry Rank

400

Key Stats

Market Cap

$21.05MUSD

29.49M AUD

Enterprise Value

$20.85MUSD

29.6M AUD

Revenue (TTM)

$1.81MUSD

2.54M AUD

EBITDA (TTM)

-$4.52MUSD

-6.41M AUD

Net Income (TTM)

-$5.11MUSD

-7.16M AUD

EBITDA Margin

-253%

Profit Margin

-282%

PS Ratio

11.6

PB Ratio

11.8

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Shane Ryan open_in_new

Founded

2010

Website

bcaldiagnostics.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
3.8%	-13%	-22%	-30%	-4.8%	-24%	-4.8%	-7%	-71%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	BDX BCAL Diagnostics Ltd Ordinary Shares ISIN: AU0000160921 Shares Out.: Shares Outstanding: 368.683M¹ TV: TradingView: ASX: BDX SA: Stock Analysis: ASX: BDX YF: Yahoo Finance: BDX.AX GF: Google Finance: ASX: BDX BA: Barron's: BDX MS: Morningstar: XASX: BDX	0.0830 AUD	TV: TradingView: ASX: BDX SA: Stock Analysis: ASX: BDX YF: Yahoo Finance: BDX.AX GF: Google Finance: ASX: BDX BA: Barron's: BDX MS: Morningstar: XASX: BDX

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About BCAL Diagnostics Ltd.

BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer. It develops BREASTESTplus, a first-in-class blood test designed to be used alongside standard mammogram in breast cancer screening. The company also develops BREASTEST, BCAL Diagnostics, and BCAL Dx. The company was incorporated in 2010 and is headquartered in Sydney, Australia.

Similar Companies

Industry: Medical Care Facilities (Australia)

Name	Market Cap (USD) diff.	PE	Country
Sonic Healthcare Ltd. ASX: SHL	$7.03B 9.85B AUD 33K%	18.0	Australia
Ramsay Health Care Ltd. ASX: RHC	$6.39B 8.95B AUD 30K%	32.8	Australia
Regis Healthcare Ltd. ASX: REG	$1.4B 1.96B AUD 7K%	51.8	Australia
Integral Diagnostics Ltd. ASX: IDX	$582.14M 815.75M AUD 3K%	58.4	Australia
Healius Ltd. ASX: HLS	$266.87M 373.96M AUD 1K%	-	Australia
Australian Clinical Labs Ltd. ASX: ACL	$254.44M 356.55M AUD 1K%	13.5	Australia

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.18B 852.82B AED 1M%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 459K%	14.9	United States
Fresenius SE & Co. KGaA XETRA: FRE	$26.68B 22.97B EUR 127K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.58B 22.02B EUR 121K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.48B 84.42B SAR 107K%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 100K%	24.6	United States

chevron_leftBack